Rockwell Medical Inc (RMTI)
1.50
+0.01
(+0.67%)
USD |
NASDAQ |
Apr 25, 16:00
1.50
0.00 (0.00%)
After-Hours: 20:00
Rockwell Medical Cash from Investing (Quarterly): 2.008M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.008M |
September 30, 2023 | -10.29M |
June 30, 2023 | -0.064M |
March 31, 2023 | 5.302M |
December 31, 2022 | 3.218M |
September 30, 2022 | -14.70M |
June 30, 2022 | -0.051M |
March 31, 2022 | 9.133M |
December 31, 2021 | 0.54M |
September 30, 2021 | -1.364M |
June 30, 2021 | 1.647M |
March 31, 2021 | -0.512M |
December 31, 2020 | 0.637M |
September 30, 2020 | 1.875M |
June 30, 2020 | -1.886M |
March 31, 2020 | 2.586M |
December 31, 2019 | 0.172M |
September 30, 2019 | -1.141M |
June 30, 2019 | -7.358M |
March 31, 2019 | 3.577M |
December 31, 2018 | 2.200M |
September 30, 2018 | 7.325M |
June 30, 2018 | 3.72M |
March 31, 2018 | -0.5218M |
December 31, 2017 | 9.322M |
Date | Value |
---|---|
September 30, 2017 | -0.5073M |
June 30, 2017 | 5.819M |
March 31, 2017 | -0.1304M |
December 31, 2016 | -2.65M |
September 30, 2016 | 2.164M |
June 30, 2016 | -0.9565M |
March 31, 2016 | -0.2024M |
December 31, 2015 | -0.4781M |
September 30, 2015 | -0.1596M |
June 30, 2015 | -20.43M |
March 31, 2015 | -0.0729M |
December 31, 2014 | -11.17M |
September 30, 2014 | -0.1845M |
June 30, 2014 | 4.877M |
March 31, 2014 | -2.330M |
December 31, 2013 | -2.160M |
September 30, 2013 | -10.18M |
June 30, 2013 | -0.1587M |
March 31, 2013 | -0.1474M |
December 31, 2012 | 10.46M |
September 30, 2012 | 3.298M |
June 30, 2012 | -2.153M |
March 31, 2012 | -0.0882M |
December 31, 2011 | -0.0749M |
September 30, 2011 | -0.1431M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-14.70M
Minimum
Sep 2022
9.133M
Maximum
Mar 2022
-0.5392M
Average
0.172M
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
Cyclacel Pharmaceuticals Inc | 0.00 |
Oragenics Inc | -1.00M |
Alpine Immune Sciences Inc | -112.70M |
Corvus Pharmaceuticals Inc | -2.318M |
MAIA Biotechnology Inc | -- |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -0.043M |
Cash from Financing (Quarterly) | -0.742M |
Free Cash Flow | -9.696M |
Free Cash Flow Per Share (Quarterly) | -0.003 |
Free Cash Flow to Equity (Quarterly) | 0.827M |
Free Cash Flow Yield | -27.78% |